Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma

Angelo Maiolino, Vania T.M. Hungria, Marcia Garnica, Gislaine Oliveira-Duarte, Luciana C.O. Oliveira, Daniel R. Mercante, Eliana C. Miranda, Adriana A. Quero, Ana L.M. Peres, José C. Barros, Paola Tanaka, Roberto P. Magalhães, Eduardo M. Rego, Irene Lorand-Metze, Carmen S.P. Lima, Ilana Z. Renault, Esteban Braggio, Carlos Chiattone, Marcio Nucci, Carmino A. de Souza

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences